Also trades as: KYNB (NASDAQ) · $vol 0M
0IL8.L LSE
Kyntra Bio, Inc.
1W: -6.9%
1M: -24.0%
3M: -17.1%
YTD: -20.6%
1Y: -32.4%
3Y: -89.7%
$6.36
-0.51 (-7.42%)
Weekly Expected Move ±5.9%
$6
$6
$6
$7
$7
Overview
News
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTM$5M
Revenue
+106.3% YoY
$183M
Net Income
+8948.1% YoY
$-38M
Free Cash Flow
-60.6% YoY
100.5%
Gross Margin
1191.5%
Op. Margin
-812.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-144.4%
ROA131.0%
ROIC32.7%
Valuation
P/E0.1
P/B-0.8
EV/EBITDA1.1
Leverage
Debt/Equity0.00
Current Ratio2.69
Interest Cov.-6.0x
Quality Scores
Piotroski F5/9
Altman Z-24.56
Beneish M0.00